| 1939-02-20 |
|
| 1939-02-20 |
Founded |
| 1940 |
Founded as Kōa Chemical Industries Co., Ltd. by Kurozumi Gō (Katsushika-ku, Tokyo) |
| 1940 |
Commenced manufacturing and sale of nutritional foods and pharmaceuticals derived from livestock organs |
| 1943 |
Renamed to Kōa Nutrition Chemical Research Institute Inc. |
| 1946 |
Entered into a joint sales agreement and capital partnership with Tanabe Pharmaceutical Co., Ltd. |
| 1946 |
Renamed to Nihon Nutrition Chemical Co., Ltd. |
| 1950 |
Commenced sales of bacterial testing products |
| 1950 |
Bacterial testing powder medium 'SS Agar Medium Eiken' |
| 1950 |
Successfully commercialized 'SS Agar Medium' (for isolation of Shigella and typhoid bacteria), contributing to national public health and disease prevention. |
| 1950 |
Renamed to Eiken Chemical Co., Ltd. on the 30th anniversary of its founding |
| 1973 |
Released live medium 'Poamedia' |
| 1975 |
Eiken Immunochemical Research Institute (Kita-ku, Tokyo: Oji branch) completed and commenced operations |
| 1975 |
Released radioimmunoassay (RIA) related reagents |
| 1975 |
Released latex agglutination slide reagents |
| 1975 |
Gestate Slide 'Eiken' |
| 1977 |
Released bacterial identification reagents |
| 1977 |
Released immunoserum test reagents developed with a pioneering method that does not dilute samples |
| 1977 |
RA77 'Eiken' |
| 1980 |
New headquarters building (Bunkyo-ku, Tokyo) completed and operations commenced |
| 1980 |
Established the Kurozumi Medical Research Promotion Foundation and awarded the first research grant |
| 1980 |
Released chemiluminescent enzyme immunoassay device 'LumiSpot AL-1000' and dedicated reagents |
| 1980 |
Commenced overseas expansion of fecal occult blood test reagents and measuring devices |
| 1994 |
Released fecal occult blood test reagents using immunochromatography |
| 1994 |
OC-HemoCatch 'Eiken' |
| 1996 |
Released fully automatic urine analysis devices 'US-3100' and 'US-3200' and dedicated reagents 'UroPaper αII Eiken' |
| 1999 |
Announced development of new gene amplification technology LAMP method |
| 1999 |
Released urine automatic analysis device 'US-2100R' |
| 2000 |
Released fecal occult blood measurement device 'OC Sensor μ' |
| 2001 |
Ended sales agreement with Tanabe Pharmaceutical and began in-house sales of clinical test reagents and devices (terminated capital partnership in 2007) |
| 2001 |
Released fecal occult blood measurement device 'OC Sensor neo' |
| 2001 |
Released fully automatic urine analysis device 'US-3100R' |
| 2001 |
Established Eiken Biological Technology (Shanghai) Co., Ltd. |
| 2005 |
Obtained ISO 13485 and ISO 9001 certifications |
| 2005 |
Signed a joint development agreement for a rapid genetic test for tuberculosis using FIND and LAMP methods |
| 2005 |
Released urine automatic analysis device 'US-1000' |
| 2006 |
Entered into a business and capital partnership with Otsuka Pharmaceutical Co., Ltd. |
| 2006 |
Released bacterial antibiotic susceptibility test reagent 'Dry Plate Eiken 192' |
| 2007 |
Participated in the Brave Circle colorectal cancer eradication campaign |
| 2007 |
Released fecal occult blood measurement device 'OC Sensor DIANA' |
| 2007 |
Absorbed and merged with Eiken Equipment Co., Ltd. |
| 2007 |
Released fully automatic analysis device 'US-3300' |
| 2007 |
Tetsuya Teramoto appointed as Representative Executive President |
